These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8905685)

  • 1. Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy.
    Kanbayashi T; Nishino S; Tafti M; Hishikawa Y; Dement WC; Mignot E
    Neuroreport; 1996 Aug; 7(12):1881-6. PubMed ID: 8905685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep.
    Mignot E; Guilleminault C; Bowersox S; Frusthofer B; Nishino S; Maddaluno J; Ciaranello R; Dement WC
    Brain Res; 1989 Jun; 490(1):186-91. PubMed ID: 2569353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.
    Nishino S; Tafti M; Reid MS; Shelton J; Siegel JM; Dement WC; Mignot E
    J Neurosci; 1995 Jul; 15(7 Pt 1):4806-14. PubMed ID: 7623112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy.
    Kanbayashi T; Honda K; Kodama T; Mignot E; Nishino S
    Neuroscience; 2000; 99(4):651-9. PubMed ID: 10974428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central administration of vitamin B12 aggravates cataplexy in canine narcolepsy.
    Honda K; Riehl J; Inoué S; Mignot E; Nishino S
    Neuroreport; 1997 Dec; 8(18):3861-5. PubMed ID: 9462456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.
    Okura M; Riehl J; Mignot E; Nishino S
    Neuropsychopharmacology; 2000 Nov; 23(5):528-38. PubMed ID: 11027918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
    Dauvilliers Y; Jennum P; Plazzi G
    Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.
    Mignot E; Nishino S; Sharp LH; Arrigoni J; Siegel JM; Reid MS; Edgar DM; Ciaranello RD; Dement WC
    J Neurosci; 1993 Mar; 13(3):1057-64. PubMed ID: 8095066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacology and neurochemistry of canine narcolepsy.
    Nishino S; Reid MS; Dement WC; Mignot E
    Sleep; 1994 Dec; 17(8 Suppl):S84-92. PubMed ID: 7701206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep.
    Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
    Nishino S; Fruhstorfer B; Arrigoni J; Guilleminault C; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1079-84. PubMed ID: 8095546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insufficient non-REM sleep intensity in narcolepsy-cataplexy.
    Khatami R; Landolt HP; Achermann P; Rétey JV; Werth E; Mathis J; Bassetti CL
    Sleep; 2007 Aug; 30(8):980-9. PubMed ID: 17702267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep.
    Renaud A; Nishino S; Dement WC; Guilleminault C; Mignot E
    Eur J Pharmacol; 1991 Nov; 205(1):11-6. PubMed ID: 1687464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep [corrected].
    Honda K; Riehl J; Mignot E; Nishino S
    Neuroreport; 1999 Sep; 10(14):3111-8. PubMed ID: 10549832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
    Shelton J; Nishino S; Vaught J; Dement WC; Mignot E
    Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor disturbances during non-REM and REM sleep in narcolepsy-cataplexy: a video-polysomnographic analysis.
    Frauscher B; Gschliesser V; Brandauer E; Schönwald SV; Falkenstetter T; Ehrmann L; Tokmak I; Poewe W; Högl B
    J Sleep Res; 2011 Dec; 20(4):514-21. PubMed ID: 21261767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for a marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy.
    Ferri R; Franceschini C; Zucconi M; Vandi S; Poli F; Bruni O; Cipolli C; Montagna P; Plazzi G
    Sleep; 2008 Oct; 31(10):1409-17. PubMed ID: 18853938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cataplexy: 'tonic immobility' rather than 'REM-sleep atonia'?
    Overeem S; Lammers GJ; van Dijk JG
    Sleep Med; 2002 Nov; 3(6):471-7. PubMed ID: 14592141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.